Envista reported Q4 2023 sales of $645.6 million, with a net loss of $217.4 million, including a $258.3 million non-cash charge. Adjusted net income was $49.7 million, and adjusted EBITDA was $100.5 million. The company's full-year results aligned with expectations, with the Orthodontic business outperforming, and Spark Aligner growing over 50%.
Reported sales for Q4 2023 were $645.6 million, with core sales declining by 2.0%.
Net loss for the quarter was $217.4 million, impacted by a $258.3 million non-cash charge related to goodwill and intangible asset impairment.
Adjusted net income was $49.7 million, or $0.29 per diluted share, compared to $91.9 million, or $0.52 per diluted share, in the same period of 2022.
Full year 2023 saw a modest decline in core growth, but the Orthodontic business outperformed, with Spark Aligner growing over 50%.
For the full year 2024, Envista expects core sales to grow low-single digits and to deliver adjusted EBITDA margins of between 16% - 17%. Margins are anticipated to accelerate through 2024.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance